12
Complete Phase I clinical study of NASH
07
Nominated top 5 for the "StarinTech BIO" Season 2
05
Selected for "Technology service support project for the next-generation medical research base development" by K-MEDI hub
04
Selected for "Research fund for the Phase I clinical study" by KDDF
09
Commencing Phase I clinical study of the NASH asset
09
07
Submission for TGA approval of Phase I clinical study of the NASH pipeline
07
03
Establishment of an Australian branch, JD Bioscience AU PTY LTD
03
01
Signed collaborative research contracts with 2 ventures
01
04 - 08
Signed collaborative research contracts with 3 ventures
01 - 03
Raised $18 million in Series B funding from investors
- Mirae Asset Capital
- Hyundai Venture Investment
- BSK Investment
- Synergy IB investment
- SV Investment
- Daily Partners
- SJ Investment Partners
- WONIK Investment partners
- Innopolis Partners
- K2 Investment
- UTC Investment
Signed collaborative research contracts with 2 pharma companies
06
Selected for a biomedical technology development business project
by the ministry of Science and ICT ('20.06~'24.12)
06
Selected for a Post-TIPS R&D business project by the Ministry of
SMEs and Startups ('20.06~'22.05)
05
Selected for the development of the energy safety technology
program by the Ministry of Trade, Industry and Energy ('20.05~'23.12)
05
04
Signed a collaborative research contract with Innovo Therapeutics
(INNOVO THERAPEUTICS)
04
01
Selected for a Development of hospitals into the innovation hubs of
the research ecosystem by the Ministry of Health and Welfare ('20.01~'22.12)
01
Signed collaborative research contract with 3 ventures
10
Entered the pre-clinical trial for the main pipeline
(a novel drug candidates for NASH)
07
Signed collaborative research contracts with 3 bio ventures
03
Opened the Seoul office
Established the R&D center at GIST, Gwangju
02
Raised $4.4 million in Series A funding from investors
- Mirae Asset Capital
- Hyundai Venture Investment
- BSK Investment
- Synergy IB investment
- Opez Investment
08
License-in 2 assets from Gwangju institute of science and technology
06
Selected for the Stepping Stone program of the ministry
of SMEs and Startups
05
Increase in capital stock
02
Obtained "Venture business" certification by KIBO
Selected U-Tech valley platform, KIBO
Selected for the TIPS R&D business project by the Ministry of
SMEs and Startups ('17.10~'19.09)
10
Raised a seed capital through Sunbo Angel Partners
08
Established JD BIOSCIENCE Inc.
07
회사명 : 회사명 / 대표 : 대표자명
주소 : OO도 OO시 OO구 OO동 123-45
사업자 등록번호 : 123-45-67890
전화 : 02-123-4567 팩스 : 02-123-4568
통신판매업신고번호 : 제 OO구 - 123호
개인정보관리책임자 : 정보책임자명
COPYRIGHT(C) 2021 JD BIOSCIENCE INC. ALL RIGHT RESERVED
